Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–71. doi:10.1016/S0140-6736(07)60917-9.
Soong D, Einarson A. Vaginal yeast infections during pregnancy. Canadian family physician Medecin de famille canadien. 2009;55(3):255–6. Epub 2009/03/14. PubMed PMID: 19282531; PubMed Central PMCID: PMCPMC2654841
Google Scholar
Dansk LI. Fluconazol Pro medicin: Pro.medine.dk; 2014 [cited 2015 03–02]. Available from: http://pro.medicin.dk/Medicin/Praeparater/3095.
Dansk LI. Brentan Pro medicine: Pro.medicin.dk; 2014 [cited 2015 03–02]. Available from: http://pro.medicin.dk/Medicin/Praeparater/4269.
Dansk LI. Brentacore Pro medicin: Pro.medicin.dk; 2014 [cited 2015 03–02]. Available from: http://pro.medicin.dk/Medicin/Praeparater/355.
Dansk LI. Canesten Pro Medicin: Pro.medicin.dk; 2014 [cited 2015 03–02]. Available from: http://pro.medicin.dk/Medicin/Praeparater/3718.
Dansk LI. Diflucan Pro Medicin: Pro.medicin.dk; 2014 [cited 2015 03–02]. Available from: http://pro.medicin.dk/Medicin/Praeparater/1209.
Dansk LI. Canvag, vaginaltabletter og creme 100 mg+10 mg-g.doc Produktresume.dk Lægemiddelstyrrelsen; 2014 [cited 2015 03–02]. Available from: http://www.produktresume.dk/docushare/dsweb/ApplySimpleSearch.
Cottreau JM, Barr VO. A review of antiviral and antifungal use and safety during pregnancy. Pharmacotherapy 2016;36(6):668-678. Epub 2016/05/04. doi: 10.1002/phar.1764. PubMed.
Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330(4):263-272. Epub 1994/01/27. doi:10.1056/nejm199401273300407. PubMed.
Zarn JA, Bruschweiler BJ, Schlatter JR. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase. Environ Health Perspect. 2003;111(3):255–61. Epub 2003/03/04. PubMed PMID: 12611652; PubMed Central PMCID: PMCPMC1241380.
Article
CAS
Google Scholar
Kjaerstad MB, Taxvig C, Nellemann C, Vinggaard AM, Andersen HR. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reproductive toxicology (Elmsford, NY). 2010;30(4):573–82. Epub 2010/08/17 doi:10.1016/j.reprotox.2010.07.009. PubMed
Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983;71(5):1495–9. Epub 1983/05/01. PubMed PMID: 6304148; PubMed Central PMCID: PMCPmc437014
Article
CAS
Google Scholar
Carter TC, Druschel CM, Romitti PA, Bell EM, Werler MM, Mitchell AA. Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol. 2008;198(2):191–e1-7. Epub 2008/01/30 doi:10.1016/j.ajog.2007.08.044. PubMed
Pilmis B, Jullien V, Sobel J, Lecuit M, Lortholary O, Charlier C. Antifungal drugs during pregnancy: an updated review. J Antimicrob Chemother 2015; 70(1):14-22. Epub 2014/09/11. doi:10.1093/jac/dku355. PubMed.
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293–342. Epub 2009/06/09. doi:10.1210/er.2009-0002. PubMed PMID: 19502515; PubMed Central PMCID: PMCPMC2726844
Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol. 2011;127(3–5):204–15. Epub 2011/09/09. doi:10.1016/j.jsbmb.2011.08.007. PubMed PMID: 21899826; PubMed Central PMCID: PMCPMC3220783
Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, Toppari J, Andersson AM, Eisenberg ML, et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev 2016;96(1):55-97. Epub 2015/11/20. doi:10.1152/physrev.00017.2015. PubMed.
Molgaard-Nielsen D, Svanstrom H, Melbye M, Hviid A, Pasternak B. Association between use of oral Fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA 2016; 315(1):58-67. Epub 2016/01/10. doi:10.1001/jama.2015.17844. PubMed.
Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet. 1997;72(3):253–6. Epub 1997/10/23 22:26. PubMed
Article
CAS
Google Scholar
Lee BE, Feinberg M, Abraham JJ, Murthy AR. Congenital malformations in an infant born to a woman treated with fluconazole. Pediatr Infect Dis J 1992; 11(12):1062-1064. Epub 1992/12/01. PubMed.
Lopez-Rangel E, Van Allen MI. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype . Birth Defects Res Part A Clin Mol Teratol 2005; 73(11):919-923. Epub 2005/11/03. doi:10.1002/bdra.20189. PubMed.
Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996; 22(2):336-340. Epub 1996/02/01. PubMed.
Norgaard M, Pedersen L, Gislum M, Erichsen R, Sogaard KK, Schonheyder HC, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother 2008; 62(1):172-176. Epub 2008/04/11. doi:10.1093/jac/dkn157. PubMed.
Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med 2013; 369(9):830-839. Epub 2013/08/30. doi:10.1056/NEJMoa1301066. PubMed.
Macleod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchison GR, et al. Androgen action in the masculinization programming window and development of male reproductive organs. Int J Androl 2010; 33(2):279-287. Epub 2009/12/17. doi:10.1111/j.1365-2605.2009.01005.x. PubMed.
Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008;118(4):1479–90. Epub 2008/03/15. doi:10.1172/jci34241. PubMed PMID: 18340380; PubMed Central PMCID: PMCPMC2267017
Christiansen S, Scholze M, Dalgaard M, Vinggaard AM, Axelstad M, Kortenkamp A, et al. Synergistic disruption of external male sex organ development by a mixture of four Antiandrogens. Environ Health Perspect. 2009;117(12):1839–46. doi:10.1289/ehp.0900689. PubMed PMID: 20049201; PubMed Central PMCID: PMCPmc2799456
Welsh M, Suzuki H, Yamada G. The masculinization programming window. Endocr Dev 2014; 27:17-27. Epub 2014/09/24. doi:10.1159/000363609. PubMed.
Kyhl HB, Jensen TK, Barington T, Buhl S, Norberg LA, Jorgensen JS, et al. The Odense child cohort: aims, design, and cohort profile. Paediatr Perinat Epidemiol 2015; 29(3):250-258. Epub 2015/03/11. doi:10.1111/ppe.12183. PubMed.
Arbuckle TE, Hauser R, Swan SH, Mao CS, Longnecker MP, Main KM, et al. Meeting report: measuring endocrine-sensitive endpoints within the first years of life. Environ Health Perspect. 2008;116(7):948–51. Epub 2008/07/17. doi:10.1289/ehp.11226. PubMed PMID: 18629319; PubMed Central PMCID: PMCPMC2453165
Swan SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res. 2008;108(2):177–84. Epub 2008/10/25. PubMed PMID: 18949837; PubMed Central PMCID: PMCPMC2775531
Article
CAS
Google Scholar
Juul A, Almstrup K, Andersson AM, Jensen TK, Jorgensen N, Main KM, et al. Possible fetal determinants of male infertility. Nat Rev Endocrinol 2014; 10(9):553-562. Epub 2014/06/18. doi:10.1038/nrendo.2014.97. PubMed.
Mendiola J, Stahlhut RW, Jorgensen N, Liu F, Swan SH. Shorter anogenital distance predicts poorer semen quality in young men in Rochester, New York. Environ Health Perspect. 2011;119(7):958–63. Epub 2011/03/08. doi:10.1289/ehp.1103421. PubMed PMID: 21377950; PubMed Central PMCID: PMCPMC3222997
Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056–61. Epub 2005/08/05. PubMed PMID: 16079079; PubMed Central PMCID: PMCPmc1280349
Article
CAS
Google Scholar
Swan SH, Sathyanarayana S, Barrett ES, Janssen S, Liu F, Nguyen RH, et al. First trimester phthalate exposure and anogenital distance in newborns. Human reproduction (Oxford, England). 2015;30(4):963–72. Epub 2015/02/24. doi:10.1093/humrep/deu363. PubMed PMID: 25697839; PubMed Central PMCID: PMCPMC4359397
Martina CA, Weiss B, Swan SH. Lifestyle behaviors associated with exposures to endocrine disruptors. Neurotoxicology. 2012;33(6):1427–33. Epub 2012/06/29. doi:10.1016/j.neuro.2012.05.016. PubMed PMID: 22739065; PubMed Central PMCID: PMCPMC3641683
Bornehag CG, Carlstedt F, Jonsson BA, Lindh CH, Jensen TK, Bodin A, et al. Prenatal phthalate exposures and anogenital distance in Swedish boys. Environ Health Perspect. 2015;123(1):101–7. Epub 2014/10/30. doi:10.1289/ehp.1408163. PubMed PMID: 25353625; PubMed Central PMCID: PMCPMC4286276
Kjaerstad MB, Nielsen F, Nohr-Jensen L, Zwisler S, Brosen K, Andersen HR. Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women. Eur J Clin Pharmacol 2010; 66(12):1189-97. Epub 2010/10/07. doi:10.1007/s00228-010-0906-2. PubMed.